Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

5,290 Journal Article Views | Journal Analytics

Mosapride in the Treatment of Gastrointestinal Disorders

Submit a Paper



Publication Date: 16 Mar 2010

Type: Review

Journal: Clinical Medicine Reviews in Therapeutics

Citation: Clinical Medicine Reviews in Therapeutics 2010:2

doi: 10.4137/CMRT.S1600

Abstract

Prokinetic drugs are being used with increasing frequency in the treatment of functional gastrointestinal disorders including functional dyspepsia (FD) and constipation-predominant Irritable Bowel Syndrome (IBS-C). Mosapride is a gastro-prokinetic agent that acts as a selective 5-HT4 agonist thereby accelerating gastric emptying. It has been used for the treatment of irritable bowel syndrome (IBS), functional dyspepsia (FD), and gastroesophageal reflux (GERD). Mosapride shares physiologic effects with previous 5-HT4 agonists, cisapride and tegaserod, but with a safer cardiac profile.


Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)






What Your Colleagues Say About Libertas Academica
The whole process from submission to publication in Genetics & Epigenetics couldn't be smoother.  Editors and editorial staff of Libertas have my highest recommendation.
Dr JC Loredo Osti (Memorial University, St Johns, Newfoundland, Canada)
More Testimonials

Quick Links


New article and journal news notification services